Larkins Resurfaces As Par’s New Injectables Chief

Former Custopharm And Hikma Exec Joins Mallinckrodt-Endo Spinoff

 
• By Dave Wallace
  
After leaving Hikma, Larkins has joined Par Health (Shutterstock)

More from Leadership

More from Generics Bulletin